We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

187 hedge funds and large institutions have $1.49B invested in Array Biopharma Inc in 2017 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 62 increasing their positions, 61 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 21

12% more funds holding

Funds holding: 167 → 187 (+20)

6% more capital invested

Capital invested by funds: $1.41B → $1.49B (+$82.4M)

10% more call options, than puts

Call options by funds: $30.6M | Put options by funds: $27.9M

2% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 61

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

Holders
187
Holders Change
+20
Holders Change %
+11.98%
% of All Funds
4.66%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.1%
New
48
Increased
62
Reduced
61
Closed
21
Calls
$30.6M
Puts
$27.9M
Net Calls
+$2.74M
Net Calls Change
-$2.54M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$137M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$65.5M
3
Millennium Management
Millennium Management
New York
+$49.4M
4
ACA
Avoro Capital Advisors
New York
+$38.5M
5
Two Sigma Investments
Two Sigma Investments
New York
+$24.3M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$41M
2
Morgan Stanley
Morgan Stanley
New York
-$28.9M
3
BI
BVF Inc
California
-$23.7M
4
O
OrbiMed
New York
-$20.3M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
DekaBank Deutsche Girozentrale
101
DekaBank Deutsche Girozentrale
Germany
$859K +$262K +24,600 +35%
State Board of Administration of Florida Retirement System
102
State Board of Administration of Florida Retirement System
Florida
$761K – – –
CCMH
103
Cornerstone Capital Management Holdings
New York
$728K +$425K +39,955 +96%
Fisher Asset Management
104
Fisher Asset Management
Washington
$697K +$131K +12,321 +19%
IBT
105
International Biotechnology Trust
United Kingdom
$693K +$133K +12,500 +19%
VOYA Investment Management
106
VOYA Investment Management
Georgia
$595K +$37.2K +3,494 +6%
PAM
107
Paradigm Asset Management
New York
$576K +$685K +64,400 New
PCM
108
Piermont Capital Management
Missouri
$562K +$669K +62,900 New
CG
109
Cutler Group
California
$539K +$522K +49,094 +436%
NSEDCP
110
NJ State Employees Deferred Compensation Plan
New Jersey
$536K – – –
PPA
111
Parametric Portfolio Associates
Washington
$536K +$162K +15,190 +34%
Legal & General Group
112
Legal & General Group
United Kingdom
$500K +$162K +15,256 +37%
CM
113
Crestline Management
Texas
$472K +$562K +52,800 New
NSIM
114
North Star Investment Management
Illinois
$447K +$426K +40,000 +400%
BCM
115
Bayesian Capital Management
New York
$442K +$526K +49,400 New
GCP
116
GSA Capital Partners
United Kingdom
$423K +$503K +47,306 New
TMAM
117
Tokio Marine Asset Management
Japan
$419K +$499K +46,900 New
NIT
118
NumerixS Investment Technologies
British Columbia, Canada
$416K +$495K +46,526 New
CI
119
Cowen Inc
New York
$381K +$453K +42,600 New
SG Americas Securities
120
SG Americas Securities
New York
$357K -$276K -25,939 -39%
PP
121
PDT Partners
New York
$353K -$5.2M -488,480 -93%
VFA
122
Virtus Fund Advisers
Connecticut
$351K -$296K -27,857 -42%
Public Employees Retirement Association of Colorado
123
Public Employees Retirement Association of Colorado
Colorado
$335K -$13.6K -1,281 -3%
UBS Group
124
UBS Group
Switzerland
$334K -$1.39M -130,204 -78%
PPCM
125
Pillar Pacific Capital Management
California
$319K – – –
3 4
5
6 7

ARRY Hedge Fund Activity: Q1 2017 in Review

187 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q1 2017, worth a combined $1.49B — up 5.9% from $1.41B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new ARRY positions and 21 closed out — a net gain of 27 holders — while 62 added to existing stakes and 61 trimmed.

The largest buyer was BlackRock, adding an estimated $137M. The largest seller was Redmile Group, cutting an estimated $41M.

  • 187 institutional investors held Array Biopharma Inc (ARRY) as of Q1 2017, up from 167 in Q4 2016.
  • Funds reported $1.49B of Array Biopharma Inc stock for Q1 2017, up 5.9% quarter-over-quarter.
  • 48 funds opened new Array Biopharma Inc positions in Q1 2017 and 21 closed out, a net change of +27 holders.
  • The largest Array Biopharma Inc buyer in Q1 2017 was BlackRock, an estimated $137M added.
  • The largest Array Biopharma Inc seller in Q1 2017 was Redmile Group, an estimated $41M sold.

Based on aggregated 13F filings for Q1 2017.